NOVEL HUMAN INTERLEUKIN-18 VARIANT AND USE THEREFOR

The present invention pertains to a novel interleukin-18 (IL-18) variant and a pharmaceutical composition using the same. Specifically, the present invention pertains to a human IL-18 variant that includes, in the amino acid sequence of wild-type human IL-18, (i) a mutation of the cysteine at positions 38, 68, 76, and 127 into serine, and (ii) a mutation of the glutamic acid at position 6 and the lysine at position 53 into alanine, said human IL-18 variant including (iii) at least 1 additional mutation. The present invention also pertains to a pharmaceutical composition including said human IL-18 variant..

Medienart:

Patent

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Europäisches Patentamt - (2022) vom: 18. Aug. Zur Gesamtaufnahme - year:2022

Sprache:

Englisch

Beteiligte Personen:

TANAKA YOSHIMASA [VerfasserIn]
SAKURABA SHUN [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
bio
C07K: Peptides (peptides containing β-lactam rings c07d; (...)
C12N: Microorganisms or enzymes; compositions thereof; pr (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2022-08-18, Last update posted on www.tib.eu: 2024-02-06, Last updated: 2024-02-09

Patentnummer:

WO2022172944

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA015017265